
The U.S. outsources control of drug prices to Canada: weird! Richard Owens in the Financial Post
Having us do the dirty work of price controls on the U.S.'s behalf is bizarre and pathetic — and dangerous, writes Richard Owens...
Having us do the dirty work of price controls on the U.S.'s behalf is bizarre and pathetic — and dangerous, writes Richard Owens...
It’s time, well past time, for government to get out of the way of innovation and put the health and well-being of Canadians...
By creating lockdowns and limiting economic and personal freedoms the public sector optimizes its own affairs at our expense, writes Richard Owens in...
On October 29, the Global Trade and Innovation Policy Alliance will be holding a summit bringing together alliance members and experts from around...
With a historic Throne Speech coming on Sept. 23, the government has many challenges to face with the current pandemic and economic crisis,...
By determinedly reducing revenues Canada not only ensures the unavailability of existing medications, it sees to it that far fewer new ones will...
OTTAWA, ON (June 2, 2020): Changes to the Patented Medicine Prices Review Board (PMPRB) have been delayed until January 2021 and a new...
Now more than ever, we should want drug companies to be able to charge high prices, writes Richard Owens in the Financial Post. Below...
Universities have relied on 'fair dealing' provisions to photocopy mountains of material and distribute them to students, writes Richard Owens. By Richard Owens,...
The internet is far better off with authoritative, factual sources of reference, such as are provided by professional, fact-checking newspapers. Google’s news service...